Anzeige
Mehr »
Login
Samstag, 02.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Technischer Ausbruch: Diese Kupferaktie ist in den letzten 52 Wochen um 300 % gestiegen! Der Durchbruch läuft!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JUGD | ISIN: CA05461V2012 | Ticker-Symbol: A4JN
Lang & Schwarz
02.11.24
09:00 Uhr
0,010 Euro
0,000
0,00 %
Branche
Rohstoffe
Aktienmarkt
Sonstige
1-Jahres-Chart
AXMIN INC Chart 1 Jahr
5-Tage-Chart
AXMIN INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,0030,01809:00
ACCESSWIRE
224 Leser
Artikel bewerten:
(1)

AXMIN INC. Provides a Corporate Update

VANCOUVER, BC / ACCESSWIRE / May 1, 2024 / AXMIN Inc. (TSXV:AXM) ("AXMIN" or the "Company") announces the following:

Arbitration

White & Case LLP, the Company's legal counsel, delivered a letter to the Ministère des Mines et de la Géologie of the Central African Republic ("CAR") to invite them to agree on an expert required to move forward with the dispute with respect to the Company's Passandro and other properties in the CAR that were confiscated. The ability to settle disputes by way of arbitration is provided under the Mining Agreement entered into by the Company's CAR subsidiary and the CAR. We look forward to CAR's response in this regard. If an acceptable response is not received, White & Case will submit the Request for Arbitration to the International Arbitration Chamber of Paris. This next step is the initial pleading in the arbitration and we intend to submit this no later than June, 2024.

Cash position

The Company continues discussions to raise capital with a number of parties. At this point there are no assurances it will be able to do so.

The Company also continues to take whatever measures are possible to reduce its cash costs. Two important measures in this regard follow:

1. The Company has advised the TSX-V that it will not be able to file its annual financial statements for 2023 on a timely basis.

2. The Company has put in place a performance share unit ("PSU") plan for its directors that will allow them to be compensated in a manner that does not require cash to be utilized. Under this plan, the three directors of the board (Lucy Yan, Joe Tai and John Gravelle, collectively "the Directors") will each receive 1,500,000 PSUs. The Company's intention is that the PSUs granted have value equal to not less than 1% of the cumulative amount that the Company receives or can reasonably expect to receive in connection with its assets in the CAR and this 1% is not subject to dilution. The 1,500,000 PSUs that the Directors each received will vest when the Company realizes a payment in connection with its assets or current or previous activities related to the CAR. The plan also allows for immediate vesting on certain events that constitute a change in control as defined in the PSU plan. The performance period for this award is March 17, 2024 to March 17, 2044 and the expiry date of this award is March 17, 2044. The Plan must be approved by the TSX-V and the Company intends to ask shareholders to approve the plan within three years. The full agreement will be circulated to shareholders when approval is sought. The Company has agreed to replace the PSU plan with a compensation plan that provides similar economics should the PSU plan not receive approval.

Chief Financial Officer

Jimmy Li, the Company's CFO, has resigned. The Company has embarked on a search to identify an appropriate replacement and wishes Mr. Li all the best in his future endeavors.

This press release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or the securities laws of any state of the United States and may not be offered or sold within the United States (as defined in Regulation S under the U.S. Securities Act) unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to an exemption from such registration requirements.

About AXMIN

AXMIN is a Canadian resource company with a strong focus on central and west Africa. For more information regarding AXMIN, visit our website at www.axmininc.com.

Please follow us on Facebook https://www.facebook.com/axmininc.

This press release includes certain "Forward-Looking Statements." All statements, other than statements of historical fact included herein, including without limitation, statements regarding future plans and objectives of AXMIN and statements regarding the arbitration it is pursuing with respect to the Passendro Gold Project, are forward-looking statements that involve various risks and uncertainties.

There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from AXMIN's expectations have been disclosed under the heading "Risk Factors" and elsewhere in AXMIN's documents filed from time-to-time with the TSX Venture Exchange and other regulatory authorities. AXMIN disclaims any intention or obligation to update or revise any forward-looking statements whether resulting from new information, future events or otherwise, except as required by applicable law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Lucy Yan
CEO and Chairman
604 488-8878
ceo@axmininc.com

General Enquiries

Investor Relations
ir@axmininc.com
www.axmininc.com

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

SOURCE: AXMIN Inc.



View the original press release on accesswire.com

© 2024 ACCESSWIRE
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.